Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease (Q35948528)

11 August 2017

Short-term clinical outcomes for stages of NIA-AA preclinical Alzheimer disease. (English)

1 reference

11 August 2017

0 references

2

1 reference

11 August 2017

7

K Kantarci

1 reference

11 August 2017

1

D S Knopman

1 reference

11 August 2017

13

R C Petersen

1 reference

11 August 2017

6

V Lowe

1 reference

11 August 2017

9

M L Senjem

1 reference

11 August 2017

5

P Vemuri

1 reference

11 August 2017

8

J L Gunter

1 reference

11 August 2017

3

H J Wiste

1 reference

11 August 2017

4

S D Weigand

1 reference

11 August 2017

11

R O Roberts

1 reference

11 August 2017

12

B F Boeve

1 reference

11 August 2017

R J Ivnik

10

1 reference

PMCID

3348848

11 August 2017

language of work or name

English

0 references

publication date

2 May 2012

1 reference

11 August 2017

1 reference

11 August 2017

78

1 reference

11 August 2017

1576-1582

1 reference

11 August 2017

20

1 reference

An operational approach to National Institute on Aging-Alzheimer's Association criteria for preclinical Alzheimer disease

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

The incidence of MCI differs by subtype and is higher in men: the Mayo Clinic Study of Aging

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Cognitive decline in prodromal Alzheimer disease and mild cognitive impairment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Transforming cerebrospinal fluid Aβ42 measures into calculated Pittsburgh Compound B units of brain Aβ amyloid

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Passive case-finding for Alzheimer's disease and dementia in two U.S. communities

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Improving CSF biomarker accuracy in predicting prevalent and incident Alzheimer disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Prevalence of mild cognitive impairment is higher in men. The Mayo Clinic Study of Aging

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Comparing predictors of conversion and decline in mild cognitive impairment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Update on the magnetic resonance imaging core of the Alzheimer's disease neuroimaging initiative

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Cognition, reserve, and amyloid deposition in normal aging

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

MRI and CSF biomarkers in normal, MCI, and AD subjects: predicting future clinical change

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Measurement of MRI scanner performance with the ADNI phantom

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Amyloid imaging in mild cognitive impairment subtypes.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Frequent amyloid deposition without significant cognitive impairment among the elderly

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Mild cognitive impairment as a diagnostic entity

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Whole brain segmentation: automated labeling of neuroanatomical structures in the human brain

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Consideration of optimal time window for Pittsburgh compound B PET summed uptake measurements

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Follow-up of [11C]PIB uptake and brain volume in patients with Alzheimer disease and controls

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Mixed brain pathologies account for most dementia cases in community-dwelling older persons.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Simplified quantification of Pittsburgh Compound B amyloid imaging PET studies: a comparative analysis.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3348848

Anterior temporal lobes and hippocampal formations: normative volumetric measurements from MR images in young adults

24 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22551733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Chi-squared and Fisher-Irwin tests of two-by-two tables with small sample recommendations

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22551733

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1212/WNL.0B013E3182563BBE

1 reference

11 August 2017

1 reference

11 August 2017

1 reference

PMCID

3348848